Subject matter expert James Leverenz, MD, explains how he distinguishes between the two main forms of this poorly understood group of dementias and where diagnosis and treatment appear to be headed.
A new episode of our “Neuro Pathways” podcast explores how key insights into this condition have shifted in recent years and why the changes raise hope for long-elusive treatment progress.
As demand swells for movement disorder expertise, a special journal issue from the World Congress on Parkinson’s Disease and Related Disorders delivers an essential update for neurologists worldwide.
The CYCLE trial showed that eight weeks of regular cycling in a lab setting improved global motor function in PD. Now a new study will assess 12 months of in-home cycling on disease progression.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
It took over six years, 20+ visits, participation in two clinical drug trials and more to convince this physician patient the time was right to try deep brain stimulation. We share caregiving lessons learned along the way.
The Director of our Center for Neurological Restoration explains this designation from the Parkinson’s Foundation, from the application process through the benefits for patient care and research.
Will we fight neurodegenerative diseases the way we robustly took on HIV/AIDS — or with the limited attention we’ve devoted to combating malaria?
Further progress against Parkinson’s disease may lie in viewing it as multiple diseases with different underlying causes and manifestations.
A study of patients’ symptom and behavioral goals prior to deep brain stimulation for Parkinson’s suggests treatment success involves far more than standard clinical metrics.
Wine experts have enhanced structural and functional measures in brain areas linked to their expertise, a new study shows. A researcher discusses potential implications for neural plasticity in adults.